Literature DB >> 15004693

Drosophila melanogaster innate immunity: an emerging role for peptidoglycan recognition proteins in bacteria detection.

J Royet1.   

Abstract

Over the past years, parallel studies conducted in mammals and flies have emphasized the existence of common mechanisms regulating the vertebrate and invertebrate innate immune systems. This culminated in the discovery of the central role of the Toll pathway in Drosophila immunity and in the implication of Toll-like receptors (TLRs)/interleukin-1(IL-1) in the mammalian innate immune response. In spite of clear similarities, such as shared intracellular pathway components, important divergences are expected between the two groups, whose last common ancestor lived more than half a billion years ago. The most obvious discrepancies lie in the mode of activation of the signalling receptors by microorganisms. In mammals, TLRs are part of protein complexes which directly recognize microbe-associated patterns, whereas Drosophila Toll functions like a classical cytokine receptor rather than a pattern recognition receptor. Recent studies demonstrate that members of the evolutionarily conserved peptidoglycan recognition protein family play an essential role in microbial sensing during immune response of Drosophila.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004693     DOI: 10.1007/s00018-003-3243-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  12 in total

Review 1.  Management of 'no-reflow' complicating reperfusion therapy.

Authors:  Kaeng W Lee; Michael S Norell
Journal:  Acute Card Care       Date:  2008

Review 2.  Pharmacological approach of no-reflow phenomenon related with percutaneous coronary interventions.

Authors:  S Jiménez Valero; R Moreno; R Martin Reyes; A Sánchez Recalde; G Galeote; L Calvo; A Villate; J L López Sendón
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-04

3.  Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience.

Authors:  W B Hillegass; N A Dean; L Liao; R G Rhinehart; P R Myers
Journal:  J Am Coll Cardiol       Date:  2001-04       Impact factor: 24.094

4.  Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction.

Authors:  Vincenzo Pasceri; Christian Pristipino; Francesco Pelliccia; Antonino Granatelli; Giulio Speciale; Adriana Roncella; Bruno Pironi; Michele Capasso; Giuseppe Richichi
Journal:  Am J Cardiol       Date:  2005-06-01       Impact factor: 2.778

5.  Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions.

Authors:  R F Wilson; D D Laxson; J R Lesser; C W White
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

6.  Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Guy Amit; Carlos Cafri; Sergei Yaroslavtsev; Shmuel Fuchs; Ora Paltiel; Akram Abu-Ful; Jean M Weinstein; Arik Wolak; Reuben Ilia; Doron Zahger
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

7.  Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.

Authors:  Costantino O Costantini; Gregg W Stone; Roxana Mehran; Eve Aymong; Cindy L Grines; David A Cox; Thomas Stuckey; Mark Turco; Bernard J Gersh; James E Tcheng; Eulogio Garcia; John J Griffin; Giulio Guagliumi; Martin B Leon; Alexandra J Lansky
Journal:  J Am Coll Cardiol       Date:  2004-07-21       Impact factor: 24.094

Review 8.  Pharmaceutical interventions for the management of no-reflow.

Authors:  Tim A Fischell
Journal:  J Invasive Cardiol       Date:  2008-07       Impact factor: 2.022

9.  Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.

Authors:  Keyur H Parikh; Milan C Chag; Kanan J Shah; Urmil G Shah; Hemang A Baxi; Anish H Chandarana; Ajay M Naik; Joyal N Shah; Hetal D Shah; Ramesh K Goyal
Journal:  Can J Physiol Pharmacol       Date:  2007 Mar-Apr       Impact factor: 2.273

Review 10.  Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Catheter Cardiovasc Interv       Date:  2008-12-01       Impact factor: 2.692

View more
  2 in total

1.  Lipoteichoic acid and lipopolysaccharide can activate antimicrobial peptide expression in the tobacco hornworm Manduca sexta.

Authors:  Xiang-Jun Rao; Xiao-Qiang Yu
Journal:  Dev Comp Immunol       Date:  2010-06-25       Impact factor: 3.636

Review 2.  Autophagy in Drosophila: from historical studies to current knowledge.

Authors:  Nitha C Mulakkal; Peter Nagy; Szabolcs Takats; Radu Tusco; Gábor Juhász; Ioannis P Nezis
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.